Efficacy and safety of long-acting pasireotide in japanese patients with acromegaly or pituitary gigantism: Results from a multicenter, open-label, randomized, phase 2 study
- behalf of SOM230C1202 study group
Research output: Contribution to journal › Article › peer-review
23
Link opens in a new tab
Citations
(Scopus)